EP2170064A4 - ANTAGONISTS 6,5-PYRROLOPIPERIDINE OF TACHYKININ RECEPTORS - Google Patents

ANTAGONISTS 6,5-PYRROLOPIPERIDINE OF TACHYKININ RECEPTORS

Info

Publication number
EP2170064A4
EP2170064A4 EP08771300A EP08771300A EP2170064A4 EP 2170064 A4 EP2170064 A4 EP 2170064A4 EP 08771300 A EP08771300 A EP 08771300A EP 08771300 A EP08771300 A EP 08771300A EP 2170064 A4 EP2170064 A4 EP 2170064A4
Authority
EP
European Patent Office
Prior art keywords
pyrrolopiperidine
antagonists
tachykinin receptors
tachykinin
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08771300A
Other languages
German (de)
French (fr)
Other versions
EP2170064A1 (en
Inventor
Jianming Bao
Robert J Devita
Huagang Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Publication of EP2170064A1 publication Critical patent/EP2170064A1/en
Publication of EP2170064A4 publication Critical patent/EP2170064A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP08771300A 2007-06-22 2008-06-18 ANTAGONISTS 6,5-PYRROLOPIPERIDINE OF TACHYKININ RECEPTORS Withdrawn EP2170064A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93686407P 2007-06-22 2007-06-22
PCT/US2008/067270 WO2009002770A1 (en) 2007-06-22 2008-06-18 6.5-pyrrolopiperidine tachykinin receptor antagonists

Publications (2)

Publication Number Publication Date
EP2170064A1 EP2170064A1 (en) 2010-04-07
EP2170064A4 true EP2170064A4 (en) 2010-08-04

Family

ID=40185984

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08771300A Withdrawn EP2170064A4 (en) 2007-06-22 2008-06-18 ANTAGONISTS 6,5-PYRROLOPIPERIDINE OF TACHYKININ RECEPTORS

Country Status (5)

Country Link
EP (1) EP2170064A4 (en)
JP (1) JP2010530874A (en)
AU (1) AU2008268667A1 (en)
CA (1) CA2690737A1 (en)
WO (1) WO2009002770A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074202B1 (en) * 2007-01-18 2011-10-14 에스케이종합화학 주식회사 Ethylene tetramerization catalyst systems and method for preparing 1-octene using the same
HRP20171739T1 (en) * 2009-11-20 2018-03-09 Tonix Pharma Holdings Limited Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
SG11201404880UA (en) 2012-02-22 2014-09-26 Leo Pharma As Novel neurokinin 1 receptor antagonist compounds
AR092211A1 (en) * 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung HYDROPIRROLOPIRROL DERIVATIVES
JP6310542B2 (en) 2013-03-15 2018-04-11 トニックス ファーマシューティカルズ， インコーポレイテッド Eutectic preparation of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
CN105579456A (en) * 2013-08-20 2016-05-11 利奥制药有限公司 A Novel Neurokinin 1 Receptor Antagonist Compound II
WO2015024203A1 (en) 2013-08-20 2015-02-26 Leo Pharma A/S Novel neurokinin 1 receptor antagonist compounds ii
SG11201701995PA (en) 2014-09-18 2017-04-27 Tonix Pharma Holdings Ltd Eutectic formulations of cyclobenzaprine hydrochloride
US11826321B2 (en) 2017-12-11 2023-11-28 Tonix Pharma Holdings Limited Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
CN111918647A (en) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 NK-1 antagonists for the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (en) * 2003-06-19 2004-12-23 Pfizer Products Inc. Nk1 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
JP2008523147A (en) * 2004-12-14 2008-07-03 メルク エンド カムパニー インコーポレーテッド Octahydropyrano [3,4-C] pyrrole tachykinin receptor antagonist

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (en) * 2003-06-19 2004-12-23 Pfizer Products Inc. Nk1 antagonist

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009002770A1 *

Also Published As

Publication number Publication date
WO2009002770A1 (en) 2008-12-31
CA2690737A1 (en) 2008-12-31
JP2010530874A (en) 2010-09-16
AU2008268667A1 (en) 2008-12-31
EP2170064A1 (en) 2010-04-07

Similar Documents

Publication Publication Date Title
EP2170064A4 (en) ANTAGONISTS 6,5-PYRROLOPIPERIDINE OF TACHYKININ RECEPTORS
FR22C1020I2 (en) C5AR ANTAGONISTS
BRPI0910592A2 (en) somatostatin receptor 2 antagonists
EP2348846A4 (en) ANTAGONISTS OF DISUBSTITUTED AZEPAINE-TYPE OREXIN RECEPTORS
EP2150115A4 (en) RECEPTOR ANTAGONISTS OF CYCLOPROPYLPYRROLIDINE OREXINE
HRP20151108T1 (en) NOGO-RECEPTOR ANTAGONISTS
ATE505467T1 (en) 2-AZA-BICYCLOÄ3.1.0UHEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
DK2089382T3 (en) Substituted diazepan compounds as orexin receptor antagonists
EP2004654A4 (en) ANTAGONISTS OF KINASE
EP2214676A4 (en) OXININE RECEPTOR ANTAGONISTS SUBSTITUTED DIAZEPAN TYPE
EP2350304A4 (en) TOLL RECEPTOR 3 ANTAGONISTS
EP2131654A4 (en) BIPYRIDINE CARBOXAMIDES, ANTAGONISTS OF THE OREXIN RECEPTOR
ATE509928T1 (en) 8-AZABICYCLOÄ3.2.1ÜOCTANE COMPOUNDS AS MU-OPIOID RECEPTOR ANTAGONISTS
BRPI0717937A2 (en) PIRAZONE COMPOUNDS AS ANTAGONISTS OF THE MINERALOCORTICIDE RECEPTOR
EP2349270A4 (en) 2,5-DISUBSTITUTED MORPHOLINE OREXIN RECEPTOR ANTAGONISTS
EP2350061A4 (en) 2,3-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS
BR112012003701A2 (en) "new quinoline-hepcidin antagonists"
EP2049110A4 (en) DIAZEPANS ANTAGONIST OF THE ORTEXIN RECEPTOR
ATE481405T1 (en) THIAZOLPYRAZOLOPYRIMIDINES AS ANTAGONISTS OF THE CRF1 RECEPTOR
BRPI0718494A2 (en) FENILSULFAMOIL BENZAMIDE DERIVATIVE AS BRADICININE ANTAGONISTS
DK2009992T3 (en) IL-8 RECEPTOR ANTAGONISTS
EP2254413A4 (en) CGRP RECEPTOR ANTAGONISTS OF THE IMIDAZOBENZAZEPINE TYPE
DK2121630T3 (en) Rapidly dissociating dopamine 2 receptor antagonists
DE602005004011D1 (en) HYDROISOINDOLIN tachykinin receptor antagonists
BRPI0720078A2 (en) 2-AMINOKINOLINES AS 5-HT RECEPTOR ANTAGONISTS (5A)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100707

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/24 20060101ALI20100701BHEP

Ipc: A61P 25/22 20060101ALI20100701BHEP

Ipc: A61P 25/06 20060101ALI20100701BHEP

Ipc: A61P 13/00 20060101ALI20100701BHEP

Ipc: A61K 31/437 20060101ALI20100701BHEP

Ipc: C07D 471/04 20060101AFI20100701BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110207